Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eprex 10,000units/1ml inj pre-filled syringes
0901030D0BBALAL
|
Eprex | Epoetin alfa | Nutrition and Blood | 33 |
|
Eprex 4,000units/0.4ml inj pre-filled syringes
0901030D0BBAKAK
|
Eprex | Epoetin alfa | Nutrition and Blood | 25 |
|
Eprex 20,000units/0.5ml inj pre-filled syringes
0901030D0BBATAT
|
Eprex | Epoetin alfa | Nutrition and Blood | 20 |
|
Eprex 40,000units/1ml inj pre-filled syringes
0901030D0BBAUAU
|
Eprex | Epoetin alfa | Nutrition and Blood | 18 |
|
Eprex 6,000units/0.6ml inj pre-filled syringes
0901030D0BBANAN
|
Eprex | Epoetin alfa | Nutrition and Blood | 14 |
|
Eprex 5,000units/0.5ml inj pre-filled syringes
0901030D0BBAMAM
|
Eprex | Epoetin alfa | Nutrition and Blood | 9 |
|
Eprex 3,000units/0.3ml inj pre-filled syringes
0901030D0BBAJAJ
|
Eprex | Epoetin alfa | Nutrition and Blood | 8 |
|
Eprex 8,000units/0.8ml inj pre-filled syringes
0901030D0BBAQAQ
|
Eprex | Epoetin alfa | Nutrition and Blood | 4 |
|
Eprex 2,000units/0.5ml inj pre-filled syringes
0901030D0BBAIAI
|
Eprex | Epoetin alfa | Nutrition and Blood | 3 |
|
Eprex 30,000units/0.75ml inj pre-filled syringes
0901030D0BBAVAV
|
Eprex | Epoetin alfa | Nutrition and Blood | 3 |
|
Eprex 1,000units/0.5ml inj pre-filled syringes
0901030D0BBAHAH
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 40,000units/1ml solution for injection vials
0901030D0BBASAS
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 7,000units/0.7ml inj pre-filled syringes
0901030D0BBAPAP
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 9,000units/0.9ml inj pre-filled syringes
0901030D0BBARAR
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.